In patients with proliferative diabetic retinopathy, ranibizumab delivered with the Port Delivery System yielded a reduced need for rescue intervention vs. panretinal photocoagulation, according to a ...

Why did a 38-year-old woman with neurofibromatosis type 1 (NF1) develop choroidal Yasunari nodules in both eyes? That's what Danish clinicians had to figure out when the patient presented for a ...

Please provide your email address to receive an email when new articles are posted on . Laser treatments, anti-VEGF injections and surgery can all be used to treat diabetic retinopathy. David Baxley, ...

In patients with proliferative diabetic retinopathy (PDR), treatment with panretinal photocoagulation (PRP) followed by anti–vascular endothelial growth factor (anti-VEGF) appears to increase ...

Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...

In patients with proliferative diabetic retinopathy, treatment with anti–vascular endothelial growth factor (anti-VEGF) may offer a safer alternative to panretinal photocoagulation (PRP), leading to ...